Pure Raw gains 100% of Nutra Pharma Series B

NUTRA PHARMA CORP (NPHC) has a new large shareholder disclosure for its Series B Preferred Shares.

Rhea-AI Filing Summary

NUTRA PHARMA CORP (NPHC) has a new large shareholder disclosure for its Series B Preferred Shares. Pure Raw Supplies, LLC, a Florida pharmaceutical consulting company, reports beneficial ownership of 12,000,000 Series B Preferred Shares, representing 100% of that class.

The shares were acquired on August 21, 2026 via a bona fide gift from Rik Deitsch, with no cash consideration or borrowed funds used. Pure Raw Supplies states it holds the shares for investment purposes and reports no current plans or proposals involving corporate actions such as mergers, asset sales, or changes in control. No contracts, arrangements, or other relationships regarding Nutra Pharma securities are disclosed beyond this ownership.

Filing Explained

The filing specifies that Pure Raw Supplies, LLC has sole voting and dispositive power over its 12,000,000 Series B preferred shares, representing 100% of that class, giving it the disclosed authority to vote and dispose of the entire Series B class.

Key Figures

Series B Preferred Shares beneficially owned: 12,000,000 shares Percent of Series B Preferred class: 100% Date of event triggering Schedule 13D: August 21, 2026 +2 more

5 metrics

Series B Preferred Shares beneficially owned 12,000,000 shares Beneficially owned by Pure Raw Supplies, LLC as reported in the Schedule 13D

Percent of Series B Preferred class 100% Percentage of Nutra Pharma Corp Series B Preferred Shares represented by 12,000,000 shares

Date of event triggering Schedule 13D August 21, 2026 Date of bona fide gift from Rik Deitsch to Pure Raw Supplies, LLC

Sole voting power 12,000,000 shares Shares over which Pure Raw Supplies, LLC has sole voting power

Sole dispositive power 12,000,000 shares Shares over which Pure Raw Supplies, LLC has sole dispositive power

Key Terms

beneficial ownership, bona fide gift, dispositive power, Schedule 13D, +1 more

5 terms

beneficial ownership financial

"Number of Shares Beneficially Owned by Each Reporting Person With:"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

bona fide gift financial

"acquired beneficial ownership of the Shares through a bona fide gift from"

A bona fide gift is a genuine, voluntary transfer of money, property, or benefits from one party to another made without expectation of repayment, services, or hidden conditions. Investors care because such gifts can affect company disclosures, related‑party transaction rules, tax treatment, and perceived conflicts of interest; think of it like someone giving you a present with no strings attached — but on a corporate scale, auditors and regulators need to verify it really is unconditional.

dispositive power financial

"Sole Dispositive Power 12,000,000.00"

Dispositive power is the authority to decide the final outcome of an asset, legal claim, contract, or corporate action — in effect the power to dispose of or resolve something. For investors it matters because whoever holds that authority can determine who gets paid, who controls an asset or vote, and how risks and returns are allocated; think of it like holding the key that lets you lock in the winner or loser in a deal.

Schedule 13D regulatory

"If the filing person has previously filed a statement on Schedule 13G"

A Schedule 13D is a legal document that investors file with regulators when they buy a large enough stake in a company to potentially influence its management or decisions. It provides details about the investor’s intention, ownership stake, and plans, helping other investors understand who is gaining control and what their motives might be.

Series B Preferred Shares financial

"Title of Class of Securities: Series B Preferred Shares"

Series B preferred shares are a class of company stock issued during a later round of private financing that gives investors priority over common shareholders for payouts and protections if the company is sold or liquidated. Think of them as a VIP ticket that often includes a fixed claim on returns, possible regular payments, and the option to convert into regular shares; that mix of safety and upside helps investors assess risk and potential reward.

FAQ

What ownership in NPHC’s Series B Preferred Shares does Pure Raw Supplies, LLC report?

Pure Raw Supplies, LLC reports beneficial ownership of 12,000,000 Series B Preferred Shares of Nutra Pharma Corp (NPHC), representing 100% of the outstanding shares of that class.

How did Pure Raw Supplies, LLC acquire its NPHC Series B Preferred Shares?

Pure Raw Supplies, LLC acquired the NPHC Series B Preferred Shares through a bona fide gift from Rik Deitsch on August 21, 2026. The filing states no funds were borrowed or used and no consideration was paid for the shares.

What is the stated purpose of Pure Raw Supplies, LLC’s investment in NPHC?

The filing states that Pure Raw Supplies, LLC holds the NPHC Series B Preferred Shares for investment purposes and that it does not presently have plans or proposals for actions such as mergers, asset sales, or other control-related changes.

Does anyone else share voting or dispositive power over NPHC shares with Pure Raw Supplies, LLC?

No. The filing reports sole voting power over 12,000,000 shares and sole dispositive power over 12,000,000 shares, with 0 shared voting or dispositive power for NPHC’s Series B Preferred Shares.

Are there any special contracts or arrangements related to Pure Raw Supplies, LLC’s NPHC holdings?

No. Under Item 6, the filing states there are no contracts, arrangements, understandings or relationships with respect to Nutra Pharma Corp securities beyond the disclosed ownership.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/01/2026 - 03:54 PM Accepted by SEC EDGAR 09/01/2026 - 03:54 PM Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13D

Under the Securities Exchange Act of 1934

Nutra Pharma Corp

(Name of Issuer)

Series B Preferred Shares

(Title of Class of Securities)

67060U208

(CUSIP Number)

Elizabeth Deitsch
7915 NW 111th Way,
Parkland, FL, 33076
954-295-7232

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

08/21/2026

(Date of Event Which Requires Filing of This Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

schemaVersion:

SCHEDULE 13D

CUSIP Number(s): 67060U208

1

Name of reporting person

Pure Raw Supplies, LLC

2

Check the appropriate box if a member of a Group (See Instructions)

(a)
(b)

3

SEC use only

4

Source of funds (See Instructions)

OO

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

6

Citizenship or place of organization

FLORIDA

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 12,000,000.00
8	Shared Voting Power 0.00
9	Sole Dispositive Power 12,000,000.00
10	Shared Dispositive Power 0.00

11

Aggregate amount beneficially owned by each reporting person

12,000,000.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

13

Percent of class represented by amount in Row (11)

100 %

14

Type of Reporting Person (See Instructions)

PN

SCHEDULE 13D

Item 1.	Security and Issuer
(a)	Title of Class of Securities: Series B Preferred Shares
(b)	Name of Issuer: Nutra Pharma Corp
(c)	Address of Issuer's Principal Executive Offices: 6400 Park of Commerce Blvd, Suite 1B, Boca Raton, FLORIDA , 33487.
Item 2.	Identity and Background
(a)	Pure Raw Supplies, LLC, a Florida limited liability company
(b)	7915 NW 111th Way, Parkland, FL 33076
(c)	The principal business of the Reporting person is pharmaceutical consulting.
(d)	During the past five years, the Reporting Person has not (i) been convicted in any criminal proceeding (excluding traffic violations or similar misdemeanors), or (ii) been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction, as a result of which it became or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.
(e)	During the past five years, the Reporting Person has not (i) been convicted in any criminal proceeding (excluding traffic violations or similar misdemeanors), or (ii) been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction, as a result of which it became or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.
(f)	FL
Item 3.	Source and Amount of Funds or Other Consideration
	The Reporting Person acquired beneficial ownership of the Shares through a bona fide gift from Rik Deitsch on August 21, 2026. No funds were borrowed or otherwise used by the Reporting Person to acquire the Shares, and no consideration was paid by the Reporting Person in connection with such acquisition
Item 4.	Purpose of Transaction
	The Reporting Person acquired the Shares pursuant to a bona fide gift and not as part of any purchase transaction. The Reporting Person holds the Shares for investment purposes. The Reporting Person does not presently have any plans or proposals that relate to or would result in any of the actions described in clauses (a) through (j) of Item 4 of Schedule 13D.
Item 5.	Interest in Securities of the Issuer
(a)	12,000,000; 100%
(b)	12,000,000
(c)	None other than the transactions described in Item 4 of this Schedule 13D.
(d)	To the knowledge of the Reporting Person, no person other than the Reporting Person has the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the Shares reported herein,
(e)	N/A
Item 6.	Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer
	None.
Item 7.	Material to be Filed as Exhibits.
	None.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Pure Raw Supplies, LLC

Signature:	/s/ Elizabeth Deitsch
Name/Title:	Elizabeth Deitsch/President
Date:	09/01/2026